STOCK TITAN
  1. Home
  2. Financials
  3. PROCF
  4. EPS (Diluted)

Sofgen Pharma S.A (PROCF) EPS by Year

PROCF OTC

Sofgen Pharma S.A lost $0.68 per diluted share in fiscal year 2024. This represents a decrease of 270.0% from the prior fiscal year. The table below carries 6 fiscal years, from 2019 to 2024, and the quarters Sofgen Pharma S.A has filed alongside them.

FY2024 annual
EPS (Diluted) -$0.68
YoY -270.0%
Source SEC Filings (20-F/6-K) Latest period FY2024, ended Dec 31, 2024 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PROCF EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-F
EPS (Diluted)-$0.68-270.0%$0.40+11.1%$0.36n/m-$1.09n/m-$0.11N/A

PROCF EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2420-FQ4'2320-FQ2'236-KQ4'2220-FQ2'226-KQ4'2120-FQ4'2020-FQ4'1920-FQ4'1820-F
EPS (Diluted)N/AN/A$0.27n/mN/A-$0.07N/AN/AN/AN/A

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Sofgen Pharma S.A financials

Frequently Asked Questions

Sofgen Pharma S.A lost $0.68 per diluted share in fiscal year 2024.

Sofgen Pharma S.A (PROCF) diluted earnings per share fell by 270.0% year over year, from $0.40 to -$0.68 in fiscal year 2024.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Sofgen Pharma S.A (PROCF) reported on that line in every period on record.